Search Diet & Weight Topics:
Page 4«..3456..1020..»

Pet Obesity Management Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2027 – Owned

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

New Jersey, United States,- The Pet Obesity Management Market research report added by Verified Market Research is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market introduction, Pet Obesity Management market definition, regional market scope, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Pet Obesity Management market size forecast, 100+ market data, Tables, Pie Chart, Graphs and Figures, and many more for business intelligence.

The Pet Obesity Management Market report includes an in-depth analysis of the Pet Obesity Management market for the present as well as the forecast period. The report encompasses the competition landscape entailing share analysis of the key players in the Pet Obesity Management market based on their revenues and other significant factors. Further, it covers several developments made by the prominent players of the Pet Obesity Management market. The Pet Obesity Management Market report is a beneficial source of perceptive data for a business approach. It presents the market overview with growth analysis together with historical & futuristic costs. Further identifies the revenue, specifications, company profile, demand, and supply data.

Global Pet Obesity Management Market was valued at USD 633.04 Million in 2019 and is projected to reach USD 1,116.55 Million by 2027, growing at a CAGR of 7.51% from 2020 to 2027.

Leading Key players of Pet Obesity Management Market are:

Pet Obesity Management Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

Pet Obesity Management Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Pet Obesity Management Market: Regional Analysis

The research report includes a detailed study of regions of North America, Europe, Asia, and South America. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

North America(United States, Canada, and Mexico)Europe(Germany, France, UK, Russia, and Italy)Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)South America(Brazil, Argentina, Colombia, etc.)The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Why purchase this report

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

View post:
Pet Obesity Management Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2027 - Owned

Extra weight can be a deadly complication when fighting COVID-19 – Kingsport Times News

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

FORT LAUDERDALE, Fla. Dr. Craig Mallaks work in the morgue tracking Broward Countys COVID-19 deaths startled him so much he shed pounds that he didnt even need to lose.

Obesity is a factor in a lot of cases, Mallak, Browards chief medical examiner, said in an email. Motivated me to lose 18 pounds in June, and Im not overweight to start with.

The dominant message so far in the pandemic is that older people are the most at risk. Thats true, but doctors on the front lines of South Floridas outbreak are also finding obesity is making it harder for people to fight off the virus, regardless of age.

That could have grave implications for the United States, which has one of the highest obesity rates in the world, said Dr. Cate Varney, an obesity specialist at the University of Virginia Health System.

A colleague asked me, Do you think it will get as bad as Italy? Varney recalled. I said, No, its going to be worse because we have higher rates of obesity. This is a definite call to action. We can start now, but we need to be prepared at the end of this pandemic to really start taking obesity more seriously.

Its not just a few extra pandemic pounds that should spark worry, according to the Centers for Disease Control and Preventions guidelines.

Specifically, people who have a body mass index greater than 30 are at higher risk, said Dr. Sunil Kumar, medical director of intensive care at Broward Health Medical Center. Body mass index varies by height and weight. A person who is off the normal weight by about 40 pounds could be considered obese, a category that includes about 30% of Floridians.

A man of average height 5 feet, 9 inches would be considered obese at 203 pounds, while a woman of average height 5 feet, 4 inches would meet that mark at 175 pounds, according to a BMI calculator.

Studies are showing that younger patients with COVID-19 who are admitted to the hospital are more likely to have obesity as an underlying factor. Thats been backed up by Kumars own observation in the ICU.

The spread of this disease has significantly changed from the first wave, Kumar said. I am seeing a lot more younger patients. I even have patients in the ICU as young as 19 who are really, really sick.

Varney, the obesity specialist, said several possible explanations exist as to why COVID-19 patients who are overweight tend to have worse outcomes. Research is still being done, and scientists dont have a definitive explanation yet.

One theory is that people with obesity have more Ace2 receptors on their cells. The virus uses these receptors to infect cells and then make copies of itself.

If you have obesity, you have more Ace2 receptors so you are going to have a higher viral load, and it takes longer for virus to get out of your body, Varney said.

People with obesity are also susceptible to low-grade chronic inflammation, which has been associated with worse outcomes.

Another factor could be that being overweight compresses the lungs, leading to smaller lung capacity.

Obesity is linked with other chronic illnesses, such as high blood pressure, heart disease and Type 2 diabetes, that heighten the risk.

This is what I am telling my obesity management patients: This is not about vanity, Varney said. This is not about looking good in clothes. What this virus has shown to us and needs to be taken seriously and recognized is the impact obesity has on your health and your life. It can be the difference between life and early death.

Obesity and other chronic diseases are showing up in medical examiner records in South Florida. For Broward County, the most-mentioned underlying condition is arteriosclerotic cardiovascular disease (a buildup of plaque in the arteries), followed by diabetes, obesity, high blood pressure, chronic kidney disease and chronic obstructive pulmonary disease, according to a South Florida Sun Sentinel analysis.

Gov. Ron DeSantis invoked the link between weight and COVID-19 hospitalizations as a reason to keep Floridas gyms open. He expressed concerns that Floridians werent getting enough exercise during the shutdown.

But Varney said telling people to eat less and exercise more is an oversimplification of a complex condition that is too often stigmatized, misunderstood and maligned by the public. Obesity has environmental, societal and genetic components that make it difficult to treat, she said.

About 30% of Floridians are obese, according to the Florida Department of Health. South Florida is better than the statewide average, but still hundreds of thousands of people are at risk. The obesity percentage in Miami-Dade and Broward is about 25%, while Palm Beach Countys is 20%.

Shevrin Jones, a state representative from Broward County, said he thinks his weight loss made a difference in his recovery from COVID-19. Jones had mild symptoms from the virus.

Jones said he weighed 461 pounds during his freshman year of college. Now, Jones, 36, is down to 211 pounds. He said he exercises five days a week and eats a healthy diet.

Health is extremely important to me, Jones said. My doctor told me he believes because of how much I exercise thats what saved me with this, having a strong immune system.

While exercising and eating healthy is good advice, it isnt a substitute for wearing a mask, washing hands and keeping physical distance from others, said Kumar, the ICU doctor.

Younger people who are at a normal weight also shouldnt let their guard down, he said. Kumar has seen otherwise healthy younger patients in the ICU.

It makes you really upset with all this disease and death that we are seeing people who are not taking this seriously, he said. The best thing for people to do is protect themselves and others.

Extra weight can be a deadly complication when fighting COVID-19 - Kingsport Times News

Pet Obesity Management Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 -…

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

New Jersey, United States,- Market Research Intellect aggregates the latest research on Pet Obesity Management Market to provide a concise overview of market valuation, industry size, SWOT analysis, revenue approximation, and regional outlook for this business vertical. The report accurately addresses the major opportunities and challenges faced by competitors in this industry and presents the existing competitive landscape and corporate strategies implemented by the Pet Obesity Management market players.

The Pet Obesity Management market report gathers together the key trends influencing the growth of the industry with respect to competitive scenarios and regions in which the business has been successful. In addition, the study analyzes the various limitations of the industry and uncovers opportunities to establish a growth process. In addition, the report also includes a comprehensive research on industry changes caused by the COVID-19 pandemic, helping investors and other stakeholders make informed decisions.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Pet Obesity Management market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Pet Obesity Management Market, By Type

Pet Obesity Management Market, By Application

Other important inclusions in the Pet Obesity Management market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Analytics as a Service Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Supply Chain Big Data Analytics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Power Management Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Deodorant Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Sex Toys Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

The rest is here:
Pet Obesity Management Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 -...

Weight Loss and Obesity Management Market Business Overview, Revenue, Price and Gross Margin, Product Specifications, Forecast 2025 – Owned

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

Global Weight Loss and Obesity Management Market Report 2019 Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Weight Loss and Obesity Management industry.

The report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Request For Discount On This Report @

For competitor segment, the report includes global key players of Weight Loss and Obesity Management as well as some small players.

market segmentation.

Chapter 16 Middle East and Africa Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

This chapter provides information about the growth of the weight loss and obesity management market in the major countries of the MEA region, such as GCC Countries, Turkey and South Africa, during the period 2018-2028.

Chapter 17 Emerging Countries Weight Loss and Obesity Management Market Analysis 2013-2017 and Forecast 2018-2028

Readers can find important factors that can significantly impact the growth of the weight loss and obesity management market in emerging countries like China, India, and Brazil during the forecast period based on the market segmentation.

Chapter 18 Competition Landscape

In this chapter, readers can find a comprehensive list of all the leading manufacturers in the weight loss and obesity management market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the players featured in the weight loss and obesity management market report are Novo Nordisk A/S, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Allergan Plc, Johnson & Johnson Services, Inc, Medtronic plc., Vivus Inc., Eisai Co., Ltd., ReShape Lifesciences, Inc, Obalon Therapeutics, Aspire Bariatrics, Allurion Technologies Inc., Nalpropion Pharmaceuticals, Inc., Beijing Noble Laser Technology Co., Ltd, and others.

Chapter 19 Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 20 Assumptions and Acronyms

This chapter helps readers understand the research methodology followed to obtain various conclusions and important qualitative information & quantitative information about the weight loss and obesity management market.

Request Sample Report @

Important Key questions answered in Weight Loss and Obesity Management market report:

What will the market growth rate, Overview, and Analysis by Type of Weight Loss and Obesity Management in 2024?

What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Weight Loss and Obesity Management market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who Are Opportunities, Risk and Driving Force of Weight Loss and Obesity Management market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Market Share

What are the opportunities and threats faced by manufacturers in the global market?

Buy This Report @

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Weight Loss and Obesity Management product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Weight Loss and Obesity Management , with price, sales, revenue and global market share of Weight Loss and Obesity Management in 2019 and 2015.

Chapter 3, the Weight Loss and Obesity Management competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Weight Loss and Obesity Management breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2019 to 2025.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2019 to 2025.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2019 to 2025.

Chapter 12, Weight Loss and Obesity Management market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.

Chapter 13, 14 and 15, to describe Weight Loss and Obesity Management sales channel, distributors, customers, research findings and conclusion, appendix and data source.

See the original post here:
Weight Loss and Obesity Management Market Business Overview, Revenue, Price and Gross Margin, Product Specifications, Forecast 2025 - Owned

From Canada To The UK, Shedding Light On Quarantine Weight – Worldcrunch

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith


There's a heaviness to the pandemic that's weighing people down, including in a very literal sense. Here in Canada, polls show that some 40% of the population gained weight since mid-March.

The issue isn't, of course, limited to this country. Nor is there one single explanation for why some people have put on a few extra kilograms of late. But governments are choosing to act now, during the pandemic, to raise awareness among their citizens.

Leading the way is the government of Great Britain, where public initiatives include a ban on television and online junk food advertising before 9 p.m. Restaurant menus will also be required to display calories, while over-the-top marketing campaigns for calorie-heavy foods will have to stop: No more chocolate bars near cash registers that encourage impulse buying.

British authorities are even considering a requirement that calories be displayed on alcoholic products. The "Better Health" campaign, as it's known, will be introduced with expanded weight management plans to serve citizens, and will run for nine months.

But governments are choosing to act now, during the pandemic, to raise awareness among their citizens.

The timing of the campaign is no coincidence: British Prime Minister Boris Johnson who lost more than 6 kgs (13 lbs) after suffering a life-threatening COVID-19 infection last May acknowledged that overweight people are more likely than people of average weight to contract the virus. About 60% of Britons are overweight, including the prime minister himself.

The food and drink industry was quick to react by saying that the initiative was a good thing, even though this kind of campaign isn't to everyone's liking, since certain products are intentionally targeted. Some companies claim that the program is unfair and prevents the British from enjoying themselves.

Here in Canada, research suggests that about 25% of the people have used self-isolating as an opportunity to change their habits and adopt healthier behaviors. But there's also evidence that more than half of the population has had more difficulty staying healthy during this period.

Gaining the infamous "quarantine 15"... Photo: Szabo Viktor

Either way, the "Great Quarantine" aside from the stress it caused has changed our habits. While it is important to stay active to successfully lose and maintain weight, it is also essential to improve diets, as most people consume more calories than they need. Snacks and sales of alcoholic beverages are increasing throughout the West.

Along with nationwide mass advertising, the British campaign will specifically target areas and groups most affected by obesity. Evidence shows that Black, Asian and minority communities are disproportionately affected by obesity and COVID-19.

The British government's effort should be acknowledged for going much further than any other campaign of its kind. First, it is timely, given the pandemic and its impact on certain demographic groups. The program addresses the taboo of obesity, an important factor in the prevention of COVID-19. It is also the first time a health-oriented program has interfered with the way products are sold in stores without using a regressive tax.

Yes, retailer revenues will be affected. But the program will only last nine months. The same goes for advertising and media revenues. But again, these measures are intended to be temporary. It is a kind of pilot project, and one that will no doubt cost the British state a lot of money for advertising and promotion.

Either way, the "Great Quarantine" aside from the stress it caused has changed our habits.

Paradoxically, the announcement of the British approach came just 10 days after the same government spent roughly $750 million on restaurant discounts to encourage its citizens to go out more. Every Monday, Tuesday and Wednesday in August, every citizen will be entitled to a savings of $15 a day every time they visit a restaurant. Any restaurant can participate in the program, even fast-food restaurants where calorie-filled and unhealthy products are sold in abundance. In this regard, there's a glaring lack of consistency.

In Canada, certain practices are already in place: For example, the number of calories is displayed next to each dish on menus. A next and necessary step is to publicly admit that our population is too fat and even fatter than before.

We should use our COVID-19 public service announcements to encourage people to exercise more and lead active lifestyles. True, the importance of protecting oneself should not be overlooked, but it's also a good opportunity to share a more positive message while giving Canadians a welcome light push.

*Sylvain Charlebois is a Professor in food distribution and policy in the Faculties of Management and Agriculture at Dalhousie University in Halifax, Canada.

**This article was translated with permission from the author.

See more from Coronavirus here

Read more:
From Canada To The UK, Shedding Light On Quarantine Weight - Worldcrunch

Clinical Trial Management System Market 2019 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast -…

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

According to a new market report published by Persistence Market Research Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019 the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.

Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Globally, the CTMS market is witnessing significant growth due to increasing R&D investment in pharmaceutical, life science and clinical research industries.

Get Sample Copy of Report @

Company Profiles:

Get To Know Methodology of Report @

It empowers organizations and research centers to enhance productivity and effectiveness of clinical trials by advancing and managing clinical trials. Integration of CTMS with hospital information system (HIS) provides more accurate and time saving documentation is also driving growth for the CTMS market. Additionally, increasing prevalence of diseases is supporting clinical trials in different regions, and increased clinical research outsourcing is playing a major role in the growth of the CTMS market.

Increasing regulatory requirements in many countries has resulted in increased complexity for clinical trial protocols. Presence of various end users such as pharmaceuticals, clinical research organizations (CRO) and healthcare providers has increased the acceptance of CTMS. The global CTMS market was estimated to be USD 844 million in 2013. It is likely to grow at a CAGR of 14% during 2013 to 2019 to reach USD 1,848.5 million in 2019.

North America is a traditional clinical trial region. Due to regulatory and legal considerations and the clinical trial market has shifted from North America to developing countries such as India and China. Clinical trials in the U.S. have been funded and sponsored by National Institute of Health (NIH), other government agencies, academic groups, voluntary health organizations and industry.

Access Full Report @

In Europe, countries in Central and Eastern Europe provide abundant chance to life science companies for clinical development. Due to governmental support and funding for biomedical sciences, Germany has become a preferred location for clinical trials.

However, Asia is the fastest growing region in the clinical trial management system market.. Improved industry regulatory laws and patent expiration laws in various countries including Japan, China and India, have led to the expansion of the clinical trials market in Asia. Asia has lower cost of conducting clinical trials compared to Europe or the U.S.

See original here:
Clinical Trial Management System Market 2019 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast -...

Increasing Incidence of Hypertension to Drive Digital Blood Pressure Monitors Market Forward – TMR Research Blog

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

Demand for digital blood pressure monitoring devices is set to grow over the next few years. An impressive growth rate is anticipated for the market of these products from 2019 to 2029. Growth opportunities to the tune of a couple of billions will emerge in the market landscape over this period, states TMRR.

Factors that are contributing to hypertension are also contributing to growth in global digital blood pressure monitors market. Changing lifestyle is a major cause of concern since the modern living comes with stressful and hectic schedules and poor diets. It is pertinent to note here that in the year of 2019, World Health Organization noted that world over 1.15 billion people suffered from the condition. It is also a significant cause of death in the world.

Get SampleCopy of this Report @

Additionally, several government initiatives in this direction are also set to generate awareness regarding hypertension and its monitoring. Database for remote care and healthcare services is also being prepared. This is what Integrated Health Model Initiative stood for American Medical Associations activity aiming at bettering healthcare outcomes by launching a data management.

Need to manage blood pressure is growing due to increasing risk of disorders associated with poor lifestyle choices. A major lifestyle issue is obesity which is growing in incidence. In the United States alone one in every six children are obese. It is also quite pertinent to note here that obesity can lead to about 60 diseases chronic diseases.

The fragmented vendor landscape of global digital blood pressure monitors market is quite competitive. Some of the key players are Omron Healthcare Welch Allyn, Inc., A&D Medical Inc., SunTech Medical, Inc., American Diagnostics Corporation, Withings, Briggs Healthcare, GE Healthcare, Kaz Inc., Microlife AG, Rossmax International Ltd., GF Health Products Inc., Spacelabs Healthcare Inc., and Philips Healthcare, among others. Players are heavily investing in development of innovative and cost effective products.

Check Table of Contents of this Report @

Like Loading...

As Head of Marketing at TMR Research, Rohit brings to the table over a decade of experience in market research and Internet marketing. His dedication, perseverance, and passion for perfection have enabled him to achieve immense success in his field. Rohit is an expert at formulating new business plans and strategies to help boost web traffic. His interests lie in writing news articles on technology,healthcare and business.View all posts by Rohit Bhisey

Go here to see the original:
Increasing Incidence of Hypertension to Drive Digital Blood Pressure Monitors Market Forward - TMR Research Blog

Awkward Conversations: The Rheumatic Disease Patient With Mental Illness – Rheumatology Network

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith



Personality disorders are relatively uncommon in the general population (only 9.1% of people are diagnosed and treated), but they are dramatically overrepresented in healthcare settings, particularly in rheumatology.

Blaney et al. writing in the January issue of Epidemiology and Psychiatric Sciences reported that immune-mediated inflammatory diseases (IMID) are associated with an increased incidence of personality disorders both before and after an IMID diagnosis. They found that among 19,572 cases of immune-mediated inflammatory diseases (IMID; including inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis) and a control population of more than 97,000 patients, the IMID cohort had a consistently increased incidence of PDs over time. Notably, the incidence of PDs was also elevated before IMID diagnosis relative to matched controls (Blaney et al., 2020).

Swedish researchers writing in 2008 in the Archives of General Psychiatry (and republished in JAMA Psychiatry), reported that patients with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis, have a higher risk of psychiatric disorders than the general population. This was a cohort study conducted between 1973 and 2004. They found a high incidence of occurrence with standardized incidence ratios for rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis were 1.45, 2.38, and 1.69, respectively, for men, and 1.36, 2.16, and 1.95, respectively, for women. "Systemic lupus erythematosus carried an increased risk of dementia and delirium. Only women with rheumatoid arthritis and systemic lupus erythematosus had an increased risk of psychotic disorders and severe depression," wrote Kristina Sundquist, M.D., Ph.D., et al.

Some studies have suggested an increase in the incidence of neuropsychiatric disorders may be due to the immunological mechanisms of the disease itself. The stress of having a rheumatic condition is a key factor as well. This study found that affective disorders, personality disorders and neurotic disorders were among the most prevalent in the study group.


There are 10 distinct types of personality disorders including: paranoid personality disorder, schizoid personality disorder, schizotypal personality disorder, antisocial personality disorder, borderline personality disorder, histrionic personality, narcissistic personality disorder, avoidant personality disorder, dependent personality disorder and obsessive compulsive personality disorder. They are characterized by rigid ways of thinking and feeling about ones self and others in a way that significantly and adversely affects function.

Patients with personality disorders tend to have excessive healthcare utilization patterns and shorter life expectancies of more than one decade shorter than the general population. The life expectancy for women with a personality disorder is 63.3 years and 59.1 for men. That mortality risk is, in part, attributable to self-harm and substance abuse but also due to comorbities, such as obesity (4.5x higher rate than the general public), cardiovascular diseases, and sleep disorders, all of which are harder to treat given the psychopathology.

That pathology interferes with the patients ability to access care and to benefit from it once they do. For example, patients with personality disorders have a harder time building rapport with providers and are more likely to be non-compliant with care recommendations.

On the far end of a pathology continuum, personality disorder patients may sabotage their own health and medical care. In one study, 16.7% of patients acknowledged intentionally making medical situations worse, 2.9% reported intentionally exercising an injury on purpose, and 4.2% of engaged in behavior to deliberately prevent wounds from healing.

Sixty-four percent of all personality disorder patients experience substantial substance abuse at least once (most commonly benzodiazepines, opiates, and stimulants) and they are also more likely to misuse prescription medication (the self-reported rate of prescription-medication misuse is 9.2% among personality disorder patients. They also tend to report more physical pain and they score twice as high on measures of pain catastrophizing.


In my own professional experience, I can attest that nearly all of the really challenging patients referred to me by my specialty physician colleagues had some manner of a personality disorder. These patients tax everyone in the system but, thankfully, there are several strategies for managing them more successfully. First, recognize and acknowledge just how challenging their presentation is and recognize how chaotic this patients own experience may be.

I do a lot of training on managing personality disorders in healthcare settings. I talk about how the emotional experience of the provider is the emotional experience of their patient. If you are made to feel inept or self-conscious, likely your patient has outsourced their own experience of feeling scrutinized. If you are made to feel angry, frustrated, or resentfulthe patient is outsourcing those turbulent, aversive feelings. The more powerful your reaction is to this patient, the more severe their turmoil.

In psychiatry and psychology, we talk a lot about countertransference, but this phenomenon is actually simpler than thatyou are the mirror for the patients emotional experience. Thinking about your reactions in that way can depersonalize and destigmatize them so they can be aired out and addressed. Discussing your reactions with your peers can unify the care team so the patient can ultimately be more effectively supported.

In the room with an agitated patient with a personality disorder, an empathic response can go a long way towards deescalating a situation. In practice, empathy may invoke the least amount of anger in patients. You will come to realize that you win by losing battles with patients. The typical power struggle a patient with a personality disorder creates is exaggerated by rigid policies, requirements and your own judgement, which will dictate when it is safe and practical to release restrictions with any particular case.


Keep messaging and behavior consistent because mental health patients may find and exploit the team member who goes off message or allows more flexibility. Meeting with the patient as a team ensures that consistency. Make a point to reinforce desired behaviors and ignore the maladaptive ones. They often act out to get your attention. After all, when they are healthy and compliant, you are less likely to give them their desired reaction.

Give these patients attention on a timecontingentrather than behaviorcontingentbasis. For example, if your patient remains agitated after your brief attempt to problem solve a non-emergent issue, you can walk away withpromise to return after a specified period of time and engage in that conversation when they are calmer. In this way, you are reinforcing their calm demeanor and healthy behavior and you can do that everywhere possible. You can also make a point to suggest healthier coping strategies.

In rheumatology cases where substance abuse or medication non-compliance can be especially risky, stick to behavioral prescriptions for stress relief. Here, I like using Eriksonian suggestions, such as, You might find that 60-second mindfulness exercise helps you regain your footing the next time someone upsets you.

This brings me to the most important directive for healthcare professionals working with challenging patients: refer them to a mental health specialist. Obviously, you will make an emergent psychology/psychiatry consult for any patient who has threatened or engages in selfharming behavior, or harm to others, but consider making that same referral for diagnostic clarification or to support the development of a more complex behavior management plan. My mental health colleagues are especially skilled at problemsolving around personality disorder patients and in addressing those problems in their own offices so that you can ultimately be more successful in yours.



Sundquist K, Li X, Hemminki K, Sundquist J. Subsequent Risk of Hospitalization for Neuropsychiatric Disorders in Patients With Rheumatic Diseases:A Nationwide Study From Sweden.Arch Gen Psychiatry.2008;65(5):501507. doi:10.1001/archpsyc.65.5.501

Blaney, Sommer, El-Gabalawy, Bernstein, Walld, Hitchon, et al. (2020). Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases. Epidemiology and Psychiatric Sciences, 29, E84.

Read more here:
Awkward Conversations: The Rheumatic Disease Patient With Mental Illness - Rheumatology Network

Why we need global co-operation more than ever: Colleges tackling the health challenges of tomorrow – Study International News

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

How do you prevent the spread of a disease that has infected over 18 million people, caused around 600,000 deaths (and counting) and paralysed economies?

In labs, national parliaments, board rooms, hospitals, the answer is clear: Collaboration.

Today we are seeing public health professionals, epidemiologists, scientists, politicians, business professionals and medical personnel focus simultaneously on COVID-19. Doctors from China flew to Italy in March bringing medical equipment. Developers are producing online teaching content about COVID-19, helping doctors and nurses in the developing world from unrelated specialisms. The World Health Organisation (WHO) is crowdsourcing what hospitals are learning, asking for anonymised COVID-19 patient records.

There are forces erecting barriers on the flipside, but public health experts know better. To slow and stop the spread of this virus, collaboration between people, industries and countries is key.

Yet for this dream scenario to become reality, the US needs agile and practical public health leaders. Universities play an outsized role in moulding the future generation that can work together efficiently, communicate appropriately and contain this pandemic.

The stakes have never been higher. Advance your public health qualification and start making a difference at these four US universities:

The College of Population Health at Thomas Jefferson University sits at the important intersection of public health and medicine.The Colleges Master of Public Health (MPH) program, accredited by the Council on Education for Public Health (CEPH), offers special one-year (accelerated) programs tailored to meet the needs of future healthcare practitioners. Students acquire strong research and policy skills that prepares them to make a difference at the patients side and in the community.

Source: Thomas Jefferson

TOP, the Time Out Program, is a one-year pathway designed for medical students who are looking to augment their medical training and prepare to lead research, policy, or advocacy endeavours in residency and practice. TOP students spend a year with the College, and take courses in the accelerated MPH program and return to complete medical school to complete their clinical training.

LEAP, Leadership in Evidence, Application and Practice program, is a one-year pathway designed to pre-med and pre-health professional students with an opportunity to use their gap year to earn an MPH degree.

The Jefferson MPH program is interdisciplinary and focuses on real world public health challenges. It places emphasis on research, healthcare quality and safety, leadership, systems thinking, health communication, global health, health equity, and disease prevention.

There is a host of structured activities to augment classroom learning, such as special lecture series, journal club, community service and an enhanced field experience. Additionally, students work closely with faculty to design and complete an independent research or thesis project on a topic of their choice.

Known as the Jefferson advantage, whichever path you take to completion accelerated (TOP or LEAP), part-time, dual-degree Jeffersons distinctive, active, collaborative, real-world curriculum prepares students to make a difference in the healthcare space and in the community.

Ready to make an impact? Click here to find out more from a virtual graduate session today.

At the University of Washington (UW) School of Public Health, students aim to produce global solutions to combat public health concerns such as clean air and water, disease prevention, depression, obesity and more.

Source: Shutterstock

To cater to everyones academic interests, topics are spread across five departments: Biostatistics, Epidemiology, Global Health, Health Services and Environmental and Occupational Health Sciences.

Within each department, some students and professors take their research efforts the extra mile.

For instance, UW Global Health Assistant Professor Kenneth Mugwanya and his research team recently received a five-year, US$3 million dollar grant from the National Institutes of Health to test the effectiveness of integrating methods of HIV prevention into sexual and reproductive health services for women in Kenya.

UW graduate student Juan Osorio-Valencia secured a Social Entrepreneurship Fellowship to investigate how affordable technology helps decontaminate water at areas where vulnerable communities live.

If you take a tour around the Rollins School of Public Health at Emory University, youll find students who aim to identify, analyse, and intervene in todays most pressing public health issues.

Source: Emory University

Hence why faculty, students, and alumni are actively engaged in its response to the COVID-19 pandemic with regular online webinars and ongoing research. Assistant professor in the Department of Epidemiology Samuel Jenness is honing the software package EpiModel that specializes in representing dynamic human contact networks to expand its applicability to a wide range of users,, including those modelling COVID-19.

University researchers were also awarded a US$6.6 million grant from the National Institutes of Health (NIH) to launch COVIDVu, a national study that will use home tests to develop estimates of the current number of COVID-19 infections and persons with antibody response nationally and across seven heavily impacted states.

Degrees that help students contribute to future crises in this vein are the Masters of Public Health (MPH) with specialisations in environmental health, epidemiology, and health policy, and the Master of Science in Public Health (MSPH) in which students can specialise in biostatistics and health services research.

All MPH and MSPH students are also required to complete an integrative learning experience in addition to the applied practice experience.

At the University of Michigans School of Public Health, there is a dynamic range of graduate programmes for those aspiring for a healthier world with compassion, innovation and inclusion.

Source: Shutterstock

Students can pick a Master of Public Health (MPH) which is the traditional degree required by statute for public health professionals working in certain classifications in many areas. For working professionals, the online MPH and online Master of Science in Population and Health Sciences offer world-class public health training, with the flexibility of an online programme.

Both provide a broad foundational curriculum. Students will be able to tackle complex health issues such as chronic and infectious diseases, obesity and food insecurity, health care quality and costs, climate change and environmental determinants of health, and socioeconomic inequalities and their impact on health, by the time they graduate.

Those aspiring to leadership positions in the administration, management, and planning of health services in public and private setting should consider the Master of Health Services Administration (MHSA). The MHSA focuses on the organisation, financing, marketing, and management of health care systems.

Improve global wellbeing with a degree in public health

Heres a new way to do study abroad during the COVID-19 pandemic and beyond

Follow this link:
Why we need global co-operation more than ever: Colleges tackling the health challenges of tomorrow - Study International News

Clinic hires nutritionist to help in obesity drive – Cumbria Crack

Aug, 11th 2020 4:46 pm, Article Recommended by Dr. J. Smith

Vanessa Brown with Bhavin Prajapati

A Carlisle-based beauty clinic has appointed a nutritionist and movement coach, with weight management very much on the national agenda.

On Monday, Prime Minister Boris Johnson announced a raft of new measures to tackle widespread obesity in Britain, with people who are overweight said to be more at risk of being seriously debilitated by coronavirus.

VL Aesthetics, in Kingmoor Road, recently welcomed Nutritionist and Movement Coach Bhavin Prajapati into its team, and the timing of his appointment could hardly be more prescient.

I was given the post around a month-and-a-half ago, so the fact that the Government has addressed obesity now is very convenient timing, said Mr Prajapati

Its definitely a step in the right direction and were waiting to see what they do next.

Ive seen a lot more people getting out and doing exercise during the lockdown, which is encouraging. Ive worked a lot in Public Health and the hard part is to get people doing things they wouldnt normally do.

Mr Prajapati, who has more than 10 years of experience working in the NHS and private sector, will be offering weight loss and body slimming programmes, and creating tailored weight management journeys for his patients.

Starting from base health check to a more advanced programme incorporating VL Aesthetics slimming technologies, personal nutrition plan and personal movement plan, the clinic can now offer a weight loss solution to everybody.

Mr Prajapati continued: The most important thing is to meet patients in person and talk to them. You can set anyone a diet and see if they stick to it, but really you need to get to know that person and find out about their lifestyle.

Ill look at small changes a person can make and try to work out the reasons why theyre overweight.

Follow-up consultations will look at whats working well and seeing if there are new goals we can set.

There is a lot more to it than coming up with a diet; its about educating people on portion sizes, relying on takeaways, and the psychological side of things. What we do is personalised to the individual and give the patient support and direction to achieve their goal.

VL Aesthetics has invested more than 5,000 in the latest state-of-the-art equipment which allows them to provide diagnostic and health consultations for clients, identifying not just their weight and BMI, but also skeletal muscle mass, waist to hip ratio, hydration, bone density and other critical parameters as markers of health.

This will complement their body contouring and weight loss medical grade equipment and expertise.

The multi-disciplined clinic has also launched Fat Dissolving Injections to further assist body contouring. Procedures are performed by VLs aesthetic nurse with 30 years of experience.

To discuss procedures with VL Aesthetics trained consultants, phone 01228 580444 or visit

Visit link:
Clinic hires nutritionist to help in obesity drive - Cumbria Crack